Browsing Pharmacy Research by Subject "Anti Human Immunodeficiency Virus Agent"
Now showing items 1-1 of 1
-
Darunavir-cobicistat versus lopinavir-ritonavir in the treatment of COVID-19 infection (DOLCI): A multicenter observational study
( Public Library of Science , 2022 , Article)Background Coronavirus Disease 2019 (COVID-19) is an evolving pandemic that urged the need to investigate various antiviral therapies. This study was conducted to compare efficacy and safety outcomes of darunavir-cobicistat ...